|
KMID : 0939920220540041175
|
|
대한암학회지
2022 Volume.54 No. 4 p.1175 ~ p.1190
|
|
|
Histopathologic and Molecular Biomarkers of PD-1/PD-L1 Inhibitor Treatment Response among Patients with Microsatellite Instability?High Colon Cancer
|
|
Hyung Jae-Won
Cho Eun-Jeong
Kim Ji-Hun
Kim Jwa-Hoon
Kim Jeong-Eun
Hong Yong-Sang
Kim Tae-Won
Sung Chang-Ohk
Kim Sun-Young
|
|
|
Abstract
|
|
|
Purpose: Recent clinical trials have reported response rates < 50% among patients treated with programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors for microsatellite instability?high (MSI-H) colorectal cancer (CRC), and factors predicting treatment response have not been fully identified. This study aimed to identify potential biomarkers of PD-1/PD-L1 inhibitor treatment response among patients with MSI-H CRC.
Materials and Methods: MSI-H CRC patients enrolled in three clinical trials of PD-1/PD-L1 blockade at Asan Medical Center (Seoul, Republic of Korea) were screened and classified into two groups according to treatment response. Their histopathologic features and expression of 730 immune-related genes from the NanoString platform were evaluated, and a machine learning?based classification model was built to predict treatment response among MSI-H CRCs patients.
Results: A total of 27 patients (15 responders, 12 non-responders) were included. A high degree of lymphocytic/neutrophilic infiltration and an expansile tumor border were associated with treatment response and prolonged progression-free survival (PFS), while mucinous/signet-ring cell carcinoma was associated with a lack of treatment response and short PFS. Gene expression profiles revealed that the interferon-γ response pathway was enriched in the responder group. Of the top eight differentially expressed immune-related genes, PRAME had the highest fold change in the responder group. Higher expression of PRAME was independently associated with better PFS along with histologic subtypes in the multivariate analysis. The classification model using these genes showed good performance for predicting treatment response.
Conclusion: We identified histologic and immune-related gene expression characteristics associated with treatment response in MSI-H CRC, which may contribute to optimal patient stratification.
|
|
|
KEYWORD
|
|
|
Microsatellite instability, Colonic neoplasms, Immune checkpoint inhibitors, Biomarker, Transcriptome profiles, Histology, Machine learning
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|